Hormones in   United States

Overview In September 2024 United States' Hormones exports accounted up to $762M and imports accounted up to $2.24B, resulting in a negative trade balance of $1.48B. Between September 2023 and September 2024 the exports of United States'   Hormones have decreased by $-440M (-36.6%) from $1.2B to $762M, while imports increased by $1.55B (225%) from $689M to $2.24B.

Destinations In September 2024, Hormones were exported mostly to Italy ($556M), Germany ($115M), France ($41.1M), Spain ($19M), and Egypt ($10M), and were imported mostly from Ireland ($1.93B), Singapore ($119M), Argentina ($99.8M), Denmark ($19.3M), and China ($18.1M).

Growth In September 2024, the decrease in Hormones's year-by-year exports was explained primarily by a decrease in exports to Spain ($-15.3M or -55.9%), Belgium ($-11.7M or -80.1%), and Canada ($-1.5M or -70.5%). In September 2024, the increase in Hormones's year-by-year imports was explained primarily by an increase in imports from Sweden ($2.83M or 257%), Switzerland ($984k or 53.2%), and Mexico ($766k or 1.13k%).